Ignite Creation Date:
2024-05-05 @ 10:30 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01127074
Status:
COMPLETED
Last Update Posted:
2010-05-20
First Post:
2010-05-18
Brief Title:
Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line KS2422
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Organization Data
Organization:
University Hospital Tuebingen
Class:
OTHER
Study ID:
01 KV 9540
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Tuebingen
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Prof D Wallwiener
Old Organization:
University of Tuebingen Dep of Obst and Gynecology
Collaborators
| Name | Class |
|---|---|
| Paul Ehrlich Institute Langen Germany | UNKNOWN |